Infinity Reports Third Quarter 2013 Financial Results and Provides Company Update

11-11-2013 Business Wire HealthComments (0)

Infinity PharmaceuticalsPharmaceutical

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its third quarter 2013 financial results and provided an update on its clinical pipeline. Earlier today, Infinity announced that five abstracts describing clinical and preclinical data for IPI-145, the company’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at the American Society of Hematology (ASH) 2013 Annual Meeting, which is being held December 7-10 i

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top